Medication info
Glimem 1/250mg Tablet

Glimem 1/250mg Tablet

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›1mg / 1 tabletMetformin Hydrochloride›250mg / 1 tablet
Manufacturer / importer
Celltrion Pharmaceutical Co., Ltd.
Appearance
White rectangular film-coated tablet
Packaging
30 tablets/PTP
Approval status
Active

MFDS item code 201107543 · Approved 2011.09.30 · Insurance code 693901200

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is usually initiated at a low dose, which may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased according to blood glucose monitoring results up to glimepiride/metformin hydrochloride 8mg/2000mg. With glimepiride as a single agent, there is generally little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage and administration of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Ingredients

Manufacturer
Celltrion Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication combines glymepiride and metformin to help improve blood sugar control in patients with Type 2 diabetes. By taking this medication along with diet control and exercise therapy, blood sugar can be effectively managed. It is used to improve blood sugar levels and assist in the management of diabetes.

How to take

Adult dose

This medicine is administered 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is usually initiated at a low dose, which may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased according to blood glucose monitoring results up to glimepiride/metformin hydrochloride 8mg/2000mg. With glimepiride as a single agent, there is generally little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage and administration of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, and it should be discontinued and a doctor consulted if kidney function deteriorates rapidly or in case of dehydration. This medication should not be used in patients with a kidney function below 45mL/min/1.73m2, and in cases of fluctuating kidney function, it should be temporarily stopped. There have been reports of an increased risk of cardiovascular mortality associated with this medication, so patients should be fully aware of the potential risks and benefits during treatment. This medication should not be administered to patients with insulin-dependent diabetes, acute metabolic acidosis, severe liver dysfunction, pregnant or nursing women, and patients with severe kidney impairment. It should be used cautiously in patients before and after surgery, with severe infections, severe trauma, malnutrition, and liver and lung dysfunction. Patients at high risk of hypoglycemia, such as the elderly, malnourished individuals, those with irregular meal intake, alcohol consumers, and patients with decreased kidney function, should be especially monitored during the first week of treatment. Gastrointestinal symptoms (such as diarrhea, nausea, vomiting, etc.) may occur while taking this medication; these symptoms are usually temporary but should be reported to a doctor if severe. In case of allergic reactions or hematological abnormalities, healthcare professionals should be notified immediately. This medication lowers blood sugar levels, and if symptoms of hypoglycemia (such as headache, dizziness, drowsiness, confusion, etc.) occur, sugar should be ingested immediately, and if severe, consultation with a healthcare professional is advised. Regular checks of blood sugar, kidney function, and vitamin B12 levels should be conducted to monitor for abnormalities, and special caution should be taken with the elderly or patients with reduced kidney function. This medication can interact with other drugs, so be sure to inform healthcare professionals if taking other medications. Pregnant women or those planning to become pregnant should receive insulin therapy instead of this medication, and nursing women should also avoid taking it. Overdosage may lead to hypoglycemia or lactic acidosis, so dosage should be strictly adhered to, and any abnormal symptoms should be promptly reported to healthcare professionals. Caution should be exercised when driving or operating machinery due to the risk of hypoglycemia or dizziness causing accidents.

Side effects

  • Lactic acidosis
  • hypoglycemia
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • indigestion
  • constipation
  • abdominal pain
Show 37 more
  • metallic taste
  • visual impairment
  • taste disorder
  • erythema
  • itching
  • urticaria
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • anemia
  • agranulocytosis
  • pancytopenia
  • peripheral neuropathy
  • increased liver enzymes
  • liver function damage
  • cholestasis
  • jaundice
  • hepatitis
  • allergic vasculitis
  • photosensitivity
  • decreased serum sodium concentration
  • hypothyroidism
  • magnesium deficiency during diarrhea
  • encephalopathy
  • hair loss
  • weight gain
  • abdominal pain
  • abdominal distension
  • vomiting
  • indigestion
  • palpitations
  • dizziness
  • diarrhea
  • nausea
  • leg edema
  • cardiac arrest
  • rectal carcinoma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and it should be kept at a safe temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

30 tablets/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.